Thursday, February 01, 2024 9:12:37 PM
Enterprise Value $194,268,000 / 1,980,000,000 = $0.0980 = 57x undervalued from $0.0017
Market Capital ***** $1,666,000 - ( just 0.9% of an Enterprise value )
Enterprise value * $194,268,000
Revenue *********** $53,102,980
Net Income ******** $15,474,453
Assets ************ $241,565,958
Liabilities ********** $55,126,912
A few examples of valuation with added steps of 100M to O/S:
Enterprise Value $194,268,000 / 980,000,000 = $0.1980 = 116x undervalued from $0.0017
Enterprise Value $194,268,000 / 1,080,000,000 = $0.1780 = 105x undervalued from $0.0017
Enterprise Value $194,268,000 / 1,180,000,000 = $0.1640 = 96x undervalued from $0.0017
Enterprise Value $194,268,000 / 1,280,000,000 = $0.1510 = 89x undervalued from $0.0017
Enterprise Value $194,268,000 / 1,380,000,000 = $0.1400 = 82x undervalued from $0.0017
Enterprise Value $194,268,000 / 1,480,000,000 = $0.1312 = 77x undervalued from $0.0017
Enterprise Value $194,268,000 / 1,580,000,000 = $0.1229 = 72x undervalued from $0.0017
Enterprise Value $194,268,000 / 1,680,000,000 = $0.1150 = 68x undervalued from $0.0017
Enterprise Value $194,268,000 / 1,780,000,000 = $0.1091 = 64x undervalued from $0.0017
Enterprise Value $194,268,000 / 1,880,000,000 = $0.1033 = 60x undervalued from $0.0017
Enterprise Value $194,268,000 / 1,980,000,000 = $0.0980 = 57x undervalued from $0.0017
Issuance Summary:
2023 - 243.3M added
----------------------------------------------------------
2022 - 108M added
----------------------------------------------------------
2021 - 109M added
----------------------------------------------------------
2020 - 76.6M added
----------------------------------------------------------
Detailed Summary:
01/09/2024 - 979,974,315 + 23M Restricted - 101,599,713
----------------------------------------------------------
10/09/2023 - 956,974,315 + 0M - Restricted - 101,599,713
08/09/2023 - 956,974,315 - 10M
04/10/2023 - 966,974,315 + 173M
01/16/2023 - 793,674,315 + 80M
----------------------------------------------------------
11/09/2022 - 713,674,315 + 0M
09/30/2022 - 713,674,315 + 51M
06/31/2022 - 662,095,768 + 22M
03/31/2022 - 640,095,768 + 35M
----------------------------------------------------------
12/31/2021 - 605,095,768 + 78M - PPS - $0.0809
03/31/2021 - 526,932,673
06/30/2021 - 562,432,673
03/31/2021 - 526,932,673
02/17/2021 - PPS - $0.1790
----------------------------------------------------------
12/31/2020 - 496,061,032
09/30/2020 - 474,870,556
06/30/2020 - 446,644,556
03/31/2020 - 419,394,556
----------------------------------------------------------
DISCLAIMER :
Trading / Investing Do your own Due Diligence.
All statements are opinions and are not investment advice.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM